ArticleJournal of clinical laboratory analysis2025
Role of Macrophage TLR4 Expression in the Immunopathogenesis of Severe Aplastic Anemia.
Article in Journal of clinical laboratory analysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundSevere aplastic anemia (SAA) is a life-threatening hematologic disorder characterized by bone marrow failure and impaired immunity. PURPOSE: Investigating the role of Toll-like receptor 4 (TLR4) highly expressing macrophages in the immunopathogenesis of SAA.
methodsMacrophage TLR4 expression levels were detected by reverse transcription quantitative polymerase chain reaction (RT-qPCR) and western blotting (WB). Knocked down or inhibited macrophage TLR4 expression, detected the pyroptosis (IL-1β, IL-18, NLRP3, caspase-1, gasdermin D) levels by RT-qPCR and WB. Using RNA sequencing to find differential genes and pathways. Co-cultured CD8+ T cells with macrophages that knocked down or inhibited TLR4, and the levels of perforin and granzyme B expression in CD8+ T cells were detected by flow cytometry. CD8+ T cells were further co-cultured with K562, and the apoptosis rate of K562 was detected.
resultsThe TLR4 in the bone marrow macrophages of patients with untreated SAA were significantly higher than those in the remission and control groups, and were negatively correlated with clinical indicators. RNA sequencing of macrophages with TLR4 knockdown showed that differentially expressed genes were enriched in the innate immune and inflammatory chemotaxis signaling pathways. After TLR4 knockout or TLR4 inhibitor addition in bone marrow macrophages of patients with untreated SAA, the mRNA and protein expression levels of pyroptosis markers interleukin (IL)-1β, IL-18, NLRP3, caspase-1, and gasdermin D were significantly lower than those in the control group. When CD8+ T cells were co-cultured with TLR4-knocked-down or inhibitor-added macrophages, the expression of perforin and granzyme B in CD8+ T cells was significantly reduced, and CD8+ T cell cytotoxicity decreased.
conclusionsInhibition of macrophage TLR4 expression in SAA patients could alleviate the over-activated cellular immune response in SAA patients by decreasing the level of pyroptosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.